TP53 and neuroblastoma: Indeed, the three neuroblastoma cell lines for which a p53 mutation has been identified by sequencing (CLB-Pe, CLB-Ma1 and SKNAS) and the IGR-N91 cell line for which a p53 mutation has been identified by northern blot and western blot analyses [26,31] remained sensitive to bortezomib.